品牌分类
- 关注表位标记
- Primary Antibodies
- Recombinant Antibodies from Human Patients
- Anti-Allergen Antibodies
- 多标签控制蛋白
- Recombinant Isotype Controls
- 抗过敏原抗体
- 重组F4/80克隆CI:A3-1
- 体内研究用重组抗体
- Recombinant F4/80 Clone CI:A3-1
- Research-Grade Biosimilars
- 关注来自人类患者的重组抗体
- 同型对照
- 重组免疫球蛋白Fc结构域（Ig-Fc结构域）
- 人源性重组抗体
- 研究级生物仿制药
- 其他产品
- 抗病毒抗体
- 重组自由轻链
- Antibodies to Epitope Tags
- Anti-Virus Antibodies
品牌咨询
- Absolute Antibody
- Absolute antibody
- NCIH520细胞专用培养基
- betarubromycin | 27267705
- m.biomart.cn/chanpin/158550_trademarkabsolute%20antibody.htm...
- #原创新人#Dyson 戴森V8 absolute 美版无线吸尘器开箱_手持式吸尘...
- 真空干燥箱的使用步骤
- 珀金埃尔默医学诊断产品(上海)有限公司
- 脑中风患者福音:美国SanBio公司治疗脑损伤TBI的再生细胞药物SB623...
- Absolute Antibody公司,absoluteantibody代理商,Absolute Antibody...
- 仪器交易网 买卖仪器、仪表更容易!
- BTB细胞专用培养基
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com
商品描述
Description:RecombinantmonoclonalantibodytoHIV-1/HIV-2protease.ManufacturedusingAbAb’sRecombinantPlatformwithvariableregions(i.e.specificity)fromthehybridoma1696.ThisisaFabfragmentwithahis-tag.
CloneNumber:1696
UniProtAccessionNumberofTargetProtein:
PublishedApplication(s):Neutralize;ELISA;WB
PublishedSpeciesReactivity:HIV-1;HIV-2
Immunogen:1696waspreparedbygeneratingahybridomacellline,fusingmyelomacellswithsplenocytesderivedfromBALB/cmiceimmunizedwithHIV-1PRinthepresenceofFreund"sadjuvant.
Specificity:1696bindstoHIV-PRofbothHIV-1andHIV-2(IgG1696:HIV-1PRpH5.7~350uM;pH7.4~100nM-HIV-2PRpH5.7nomeasurableinteraction;pH7.4~30nM--Fab1696:HIV-1PRpH5.7~410nM;pH7.4~130nM-HIV-2PRpH5.7nomeasureableinteraction;pH7.4~40nM--determinedbyELISA).TheantibodybindstotheN-terminalregionoftheenzyme,andbindingisinhibitedbythepeptidefragmentPQITLWQwhichrepresentsresidues1-7.Westernblotbindingassaysshowthat1696recognizesthematureandprocessedformoftheenzyme,butnottheprecursorwhichpossesses20residuesupstreamfromthecleavagesite.TheN-terminushasawellconservedstructurebetweenHIV-1PRandHIV-2PR.HIV-PRisahomodimericapartateproteasethatspecificallycleavestheviralGagandGag/Polpolyproteinprecursor.Acorrelationhasbeenobservedbetweentheactivityoftheproteaseandthedegreeofinfectivity,andsothisproteinisamajorantiviraltarget.
ApplicationNotes:1696mAbcaninhibitthecatalyticactivityofbothHIV-1andHIV-2HIV-PR(1696IgGHIV-1PRIC50~0.6nM;HIV-2PRIC50~1.5nM--1696FabHIV-1PRIC50~1.1nM;HIV-2PRIC50~2.6nM).Inhibitionby1696ismediatedbythedestABIlizationoftheoftheactiveformoftheactiveHIV-PRhomodimerthroughbindingtotheN-terminus,whichconstitutesalargepercentageoftheinterfacebetweenthemonomers.TheFabfragmentwasgeneratedbyincubationoftheantibodywithpepsin.Bindingconstantsof1696canbedeterminedbyELISA.1696showsreactivitytothematureprocessedHIV-PRandnottotheprecursorbyWB.
AntibodyFirstPublishedin:
Lescaretal.InhibitionoftheHIV-1andHIV-2proteasesbyamonoclonalantibodyProteinSci.1999Dec;8(12):2686–2696.Noteonpublication:DescribesthegenerationofthemAb1696,itsfunctionalcharacterizationandthedeterminationofthecrystalstructureoftheFabfragment.
Suppliedin:PBSwithpreservative(0.02%Proclin300)
StorageRecommendation:Storeat4°Cforupto3months.Forlongertermstoragealiquotintosmallvolumesandstoreat-20°C
Concentration:Seeviallabel.
Importantnote–Thisproductisforresearchuseonly.Itisnotintendedforuseintherapeuticordiagnosticproceduresforhumansoranimals. Absolute Antibody英国牛津大学Hutchings博士和Barclay教授创办的第二代抗体公司，可以在两周内提供100mg级的工程化抗体，并且没有动物成分，批间差很小，消除因补体和Fc受体造成的背景，使结果更干净。该公司的成立顺应了Nature杂志为首的科学界提倡改变目前抗体供应混乱状况的时代潮流。 ThisreformattedmouseantibodywasmadeusingthevariabledomainsequencesoftheoriginalMouseIgGformat,forimprovedcompatibilitywithexistingreagents,assaysandtechniques.
SpeciesandIsotype:MouseFabfragment,His-Tagged,kappaCloneNumber:1696
UniProtAccessionNumberofTargetProtein:
PublishedApplication(s):Neutralize;ELISA;WB
PublishedSpeciesReactivity:HIV-1;HIV-2
Immunogen:1696waspreparedbygeneratingahybridomacellline,fusingmyelomacellswithsplenocytesderivedfromBALB/cmiceimmunizedwithHIV-1PRinthepresenceofFreund"sadjuvant.
Specificity:1696bindstoHIV-PRofbothHIV-1andHIV-2(IgG1696:HIV-1PRpH5.7~350uM;pH7.4~100nM-HIV-2PRpH5.7nomeasurableinteraction;pH7.4~30nM--Fab1696:HIV-1PRpH5.7~410nM;pH7.4~130nM-HIV-2PRpH5.7nomeasureableinteraction;pH7.4~40nM--determinedbyELISA).TheantibodybindstotheN-terminalregionoftheenzyme,andbindingisinhibitedbythepeptidefragmentPQITLWQwhichrepresentsresidues1-7.Westernblotbindingassaysshowthat1696recognizesthematureandprocessedformoftheenzyme,butnottheprecursorwhichpossesses20residuesupstreamfromthecleavagesite.TheN-terminushasawellconservedstructurebetweenHIV-1PRandHIV-2PR.HIV-PRisahomodimericapartateproteasethatspecificallycleavestheviralGagandGag/Polpolyproteinprecursor.Acorrelationhasbeenobservedbetweentheactivityoftheproteaseandthedegreeofinfectivity,andsothisproteinisamajorantiviraltarget.
ApplicationNotes:1696mAbcaninhibitthecatalyticactivityofbothHIV-1andHIV-2HIV-PR(1696IgGHIV-1PRIC50~0.6nM;HIV-2PRIC50~1.5nM--1696FabHIV-1PRIC50~1.1nM;HIV-2PRIC50~2.6nM).Inhibitionby1696ismediatedbythedestABIlizationoftheoftheactiveformoftheactiveHIV-PRhomodimerthroughbindingtotheN-terminus,whichconstitutesalargepercentageoftheinterfacebetweenthemonomers.TheFabfragmentwasgeneratedbyincubationoftheantibodywithpepsin.Bindingconstantsof1696canbedeterminedbyELISA.1696showsreactivitytothematureprocessedHIV-PRandnottotheprecursorbyWB.
AntibodyFirstPublishedin:
Lescaretal.InhibitionoftheHIV-1andHIV-2proteasesbyamonoclonalantibodyProteinSci.1999Dec;8(12):2686–2696.Noteonpublication:DescribesthegenerationofthemAb1696,itsfunctionalcharacterizationandthedeterminationofthecrystalstructureoftheFabfragment.
ProductForm
Purification:PurifiedbyImmobilizedMetalAffinityChromatographySuppliedin:PBSwithpreservative(0.02%Proclin300)
StorageRecommendation:Storeat4°Cforupto3months.Forlongertermstoragealiquotintosmallvolumesandstoreat-20°C
Concentration:Seeviallabel.
